Progressive kaposiform hemangioendothelioma and sirolimus-related severe thrombocytopenia

Thumbnail Image
Files
IJDVL2023v89n1p54.pdf (7.3 MB)
Date
2023-02
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Scientific Scholar
Abstract
Kaposiform hemangioendothelioma is a locally invasive tumor and we were unable to find any previous reports of multifocal progression. Sirolimus, a mammalian target of rapamycin inhibitor, has been widely used to treat kaposiform hemangioendothelioma. Herein, we report a case of multifocal progressive kaposiform hemangioendothelioma, wherein sirolimus treatment caused severe thrombocytopenia. A 12-year-old East Asian girl presented with indurated dark-purple masses on her back. The patient had received three surgical interventions following the first appearance of the masses in 2012 and subsequent reappearances in 2014 and 2016. Kaposiform hemangioendothelioma was diagnosed based on radiological and pathological findings. Two more masses appeared in the following year. The patient was treated with oral sirolimus (2.5 mg/ m2/day) and developed grade 3 thrombocytopenia 8 days later. The patient was uneventfully relieved 5 days later after the withdrawal of sirolimus and the administration of appropriate medications. This rare case indicated that kaposiform hemangioendothelioma could be progressive with local metastatic characteristics in children. Besides, the severe sirolimus-induced complication highlights the importance of serum drug level monitoring during treatment. Physicians should be extremely cautious while treating kaposiform hemangioendothelioma patients with sirolimus.
Description
Keywords
Kaposiform hemangioendothelioma, sirolimus, thrombocytopenia
Citation
Ying, Hanru
Qiao, Congzhen
Wang, Lizhen
Lin, Xiaoxi. Progressive kaposiform hemangioendothelioma and sirolimus-related severe thrombocytopenia. Indian Journal of Dermatology, Venereology and Leprology. 2023 Feb; 89(1): 54-59
URI
https://imsear.searo.who.int/handle/123456789/223168
Collections
Indian Journal of Dermatology, Venereology and Leprology